Mosapride citrate

Spécifications

112885-42-4Numéro CAS

601-211-6Numéro CE

4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acidNom IUPAC

C27H33ClFN3O10Formule chimique

614 g/molMasse molaire

Mosapride citrate; 112885-42-4; Gasmotin; AS-4370; Rimopride citrate; DTXSID7046207; MF497J489P; DTXCID5026207; RefChem:159819; 4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide 2-hydroxypropane-1,2,3-tricarboxylate; MFCD01666680; Gasmot; 4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide citrate; CAS-112885-42-4; C27H33ClFN3O10; UNII-MF497J489P; (+-)-4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide citrate; MLS006011997; SCHEMBL258620; MOSAPRIDE CITRATE [MI]; orb1226951; orb1300628; CHEMBL1733174; HY-B0189A; HUZTYZBFZKRPFG-UHFFFAOYSA-N; GLXC-07696; HMS2051P15; HMS2234K07; HMS3369K19; HMS3393P15; HMS3651O09; HMS3884E13; HMS5079L17; MOSAPRIDE CITRATE [WHO-DD]; Tox21_111874; HB1737; s1385; Mosapride citrate - Bio-X trade mark; AKOS015895400; Tox21_111874_1; CCG-100966; CCG-270241; FM32515; NC00216; NCGC00160527-03; AS-13388; BM164611; DA-65617; SW197596-2; T6597; D70344; Q27283985; (+/-)-4-AMINO-5-CHLORO-2-ETHOXY-N-((4-(P-FLUOROBENZYL)-2-MORPHOLINYL)METHYL)BENZAMIDE CITRATE; 2-Hydroxypropane-1,2,3-tricarboxylic acid--4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide (1/1); 4-Amino-5-chloro-2-ethoxy-N-[[4-[(4 -fluorophenyl)methyl]-2-morpholinyl]methyl]benzami de citrate; 4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;citric acid; Mosapride Citrate Dihydrate; Mosaprid citrat dihydratSynonymes